Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial
Top Cited Papers
- 22 February 2008
- journal article
- research article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 7 (4), 299-309
- https://doi.org/10.1016/s1474-4422(08)70044-9
Abstract
No abstract availableFunding Information
- Pfizer
- GlaxoSmithKline
This publication has 34 references indexed in Scilit:
- Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational studyThe Lancet, 2007
- Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trialsThe Lancet, 2004
- Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 HoursStroke, 2002
- Diffusion‐ and perfusion‐weighted MRI response to thrombolysis in strokeAnnals of Neurology, 2001
- Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging.Archives of Neurology, 2001
- Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI.Stroke, 1999
- Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRINeurology, 1998
- Tissue Plasminogen Activator for Acute Ischemic StrokeThe New England Journal of Medicine, 1995
- Acute human stroke studied by whole brain echo planar diffusion‐weighted magnetic resonance imagingAnnals of Neurology, 1995
- Recovery of Brain Function After IschaemiaActa neurochirurgica. Supplement, 1987